収益の観点から見た世界の光学イメージング市場の価値は、2022 年に 売上ベースで15 億ドルと推定され、2027 年までに 29 億ドルに達し、2022 年から 2027 年までのCAGRは13.5% と推定されます。光学イメージング市場の著名なプレーヤーには、Carl Zeiss Meditec (ドイツ)、Abbott (米国)、トプコン (日本)、キヤノン (日本)、PerkinElmer (米国)、Koninklijke Philips (オランダ)、Heidelberg Engineering (米国)、Leica Microsystems (ドイツ)、Headwall Photonics (米国)、Visionix (米国)、Optical Imaging (イスラエル)、Optos (スコットランド)、Wasatch Photonics (米国)、ArcScan (米国)、DermaLumics (スペイン)、Cylite (オーストラリア)、MOPTIM (広東省) )、Michelson Diagnostics (英国)、Thorlabs (米国)、浜松ホトニクス (日本)、iTheraMedical (ドイツ)、Kibero (ドイツ)、Seno Medical (米国)、Aspectus Imaging (ドイツ)、および Agfa-Gevaert (ベルギー)などがあります。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 33)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKETS COVERED
FIGURE 1 OPTICAL IMAGING MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
1.8 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY (Page No. - 38)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 9 COUNTRY-LEVEL ANALYSIS OF GLOBAL MARKET
FIGURE 10 APPROACH 4: TOP-DOWN APPROACH
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MARKET
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSUMPTIONS
2.5 ASSUMPTIONS
3 EXECUTIVE SUMMARY (Page No. - 51)
FIGURE 14 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GLOBAL MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GLOBAL MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GLOBAL MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION)
FIGURE 18 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 19 GEOGRAPHICAL SNAPSHOT OF GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 55)
4.1 GLOBAL MARKET OVERVIEW
FIGURE 20 INCREASING PREVALENCE OF EYE DISORDERS TO DRIVE GROWTH IN GLOBAL MARKET
4.2 NORTH AMERICA: MARKET, BY APPLICATION AND COUNTRY
FIGURE 21 PATHOLOGICAL IMAGING SYSTEMS DOMINATED MARKET IN 2021
4.3 REGIONAL MIX: GLOBAL MARKET
FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.4 GLOBAL MARKET: REGIONAL SNAPSHOT
FIGURE 23 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 58)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 OPTICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing geriatric population and subsequent increase in prevalence of eye disorders
FIGURE 25 PERCENTAGE OF GERIATRIC POPULATION, BY REGION
TABLE 1 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION)
5.2.1.2 Technological innovations
5.2.1.3 Growing application areas of optical imaging techniques
5.2.1.4 Growing need to minimize use of radiation technologies
TABLE 2 KEY MARKET DRIVERS
5.2.2 RESTRAINTS
5.2.2.1 Reimbursement challenges
5.2.2.2 Lack of skilled operators
TABLE 3 KEY MARKET RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion and market penetration opportunities in emerging economies
TABLE 4 GERIATRIC POPULATION TREND IN DEVELOPING REGIONS, 2020 AND 2060
5.2.3.2 Growing applications in pharmaceutical & biotechnology research
TABLE 5 KEY MARKET OPPORTUNITIES
5.2.4 CHALLENGES
5.2.4.1 Sustainability of small and medium-sized players
5.2.4.2 High cost of optical imaging procedures and extensive data requirements
TABLE 6 KEY MARKET CHALLENGES
5.3 PORTER’S FIVE FORCES ANALYSIS
FIGURE 26 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 GLOBAL MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT FROM NEW ENTRANTS
5.3.2 THREAT FROM SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 VALUE CHAIN ANALYSIS
FIGURE 27 GLOBAL MARKET: VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 28 GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
5.6 REGULATORY ANALYSIS
TABLE 8 STRINGENCY OF REGULATIONS FOR OPTICAL IMAGING PRODUCTS,
BY REGION
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
5.6.1.2 Canada
TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.6.2 EUROPE
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6.3.2 China
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
5.7 PATENT ANALYSIS
5.8 PRICING ANALYSIS
5.9 TRADE DATA
5.9.1 US
TABLE 13 TOP SUPPLIERS AND BUYERS OF OPTICAL IMAGING SYSTEMS IN US, 2020
5.9.2 CHINA
5.9.3 UK
5.9.4 INDIA
6 OPTICAL IMAGING MARKET, BY PRODUCT (Page No. - 78)
6.1 INTRODUCTION
TABLE 14 GLOBAL MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
6.2 IMAGING SYSTEMS
TABLE 15 IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 16 IMAGING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.2.1 OPTICAL IMAGING SYSTEMS
6.2.1.1 Growing need for high-resolution imaging in ophthalmology to drive market growth
TABLE 17 KEY OPTICAL IMAGING SYSTEMS
TABLE 18 OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.2.2 SPECTRAL IMAGING SYSTEMS
6.2.2.1 Growing need for advanced imaging techniques to promote growth
TABLE 19 SPECTRAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.3 CAMERAS
6.3.1 BENEFITS SUCH AS BETTER SENSITIVITY AND HIGH-RESOLUTION IMAGING CAPABILITIES TO DRIVE DEMAND FOR CAMERAS
TABLE 20 OPTICAL IMAGING CAMERAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.4 SOFTWARE
6.4.1 GROWING DEMAND FOR ADVANCED AND OPTIMIZED OPTICAL IMAGING SOFTWARE TO SUPPORT GROWTH
TABLE 21 OPTICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5 LENSES
6.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGING TO BOOST DEMAND FOR LENSES
TABLE 22 OPTICAL IMAGING LENSES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.6 ILLUMINATION SYSTEMS
6.6.1 GROWING DEMAND FOR NON-IONIZING AND RADIATION-FREE TECHNIQUES TO BOOST MARKET GROWTH
TABLE 23 OPTICAL IMAGING ILLUMINATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.7 OTHER PRODUCTS
TABLE 24 OTHER OPTICAL IMAGING PRODUCTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7 OPTICAL IMAGING MARKET, BY TECHNIQUE (Page No. - 90)
7.1 INTRODUCTION
TABLE 25 GLOBAL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
7.2 OPTICAL COHERENCE TOMOGRAPHY (OCT)
7.2.1 RISING INNOVATIONS IN OCT TO DRIVE MARKET GROWTH
TABLE 26 OPTICAL COHERENCE TOMOGRAPHY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.3 NEAR-INFRARED SPECTROSCOPY (NIRS)
7.3.1 INCREASING FUNDS BY GOVERNMENT ORGANIZATIONS AND UNIVERSITIES FOR R&D TO PROMOTE MARKET GROWTH
TABLE 27 NEAR-INFRARED SPECTROSCOPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.4 HYPERSPECTRAL IMAGING (HSI)
7.4.1 GROWING INDUSTRIAL APPLICATIONS OF HYPERSPECTRAL IMAGING TO BOOST GROWTH
TABLE 28 HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.5 PHOTOACOUSTIC TOMOGRAPHY (PAT)
7.5.1 RISING CANCER CASES AND BROAD APPLICATIONS IN RESEARCH AND CLINICAL CARE TO SUPPORT GROWTH
TABLE 29 PHOTOACOUSTIC TOMOGRAPHY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8 OPTICAL IMAGING MARKET, BY APPLICATION (Page No. - 97)
8.1 INTRODUCTION
TABLE 30 GLOBAL MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
8.2 PATHOLOGICAL IMAGING
8.2.1 LOW OPERATIONAL COSTS AND RELATIVE EASE OF USE TO DRIVE GROWTH
TABLE 31 PATHOLOGICAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.3 INTRA-OPERATIVE IMAGING
8.3.1 RISING LABOR COSTS AND INCREASING NEED FOR ACCURACY IN MEDICAL PROCESSES TO DRIVE MARKET
TABLE 32 INTRA-OPERATIVE IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
9 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA (Page No. - 101)
9.1 INTRODUCTION
TABLE 33 GLOBAL MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
9.2 OPHTHALMOLOGY
9.2.1 GROWING NUMBER OF OPHTHALMIC PROCEDURES TO PROPEL MARKET
TABLE 34 GLOBAL MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
9.3 ONCOLOGY
9.3.1 GROWING PRECLINICAL DRUG DEVELOPMENT RESEARCH ON CANCER TO PROMOTE GROWTH
TABLE 35 GLOBAL MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
9.4 CARDIOLOGY
9.4.1 ADVANCED INNOVATIONS IN OCT TECHNIQUES FOR CARDIOLOGY APPLICATIONS TO BOOST MARKET
TABLE 36 GLOBAL MARKET FOR CARDIOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
9.5 DERMATOLOGY
9.5.1 GROWING INCIDENCE OF SKIN CANCER TO FUEL DEMAND FOR OPTICAL IMAGING
TABLE 37 GLOBAL MARKET FOR DERMATOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
9.6 NEUROLOGY
9.6.1 LOW COST AND GROWING UTILIZATION OF OPTICAL IMAGING TECHNIQUES TO PROMOTE GROWTH
TABLE 38 GLOBAL MARKET FOR NEUROLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
9.7 OTHER THERAPEUTIC AREAS
TABLE 39 GLOBAL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2020-2027 (USD MILLION)
10 OPTICAL IMAGING MARKET, BY END USER (Page No. - 110)
10.1 INTRODUCTION
TABLE 40 GLOBAL MARKET, BY END USER, 2020-2027 (USD MILLION)
10.2 HOSPITALS & CLINICS
10.2.1 INCREASING CLINICAL APPLICATIONS OF OPTICAL IMAGING TECHNIQUES IN HOSPITALS TO DRIVE MARKET
TABLE 41 GLOBAL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
10.3 RESEARCH LABORATORIES
10.3.1 AVAILABILITY OF RESEARCH FUNDING FROM PRIVATE AND GOVERNMENT ORGANIZATIONS TO PROMOTE GROWTH
TABLE 42 GLOBAL MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.4.1 GREATER UTILIZATION OF OPTICAL IMAGING TECHNIQUES IN DRUG DISCOVERY PROCESSES TO SUPPORT MARKET
TABLE 43 GLOBAL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
11 OPTICAL IMAGING MARKET, BY REGION (Page No. - 117)
11.1 INTRODUCTION
FIGURE 29 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 44 GLOBAL MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 30 NORTH AMERICA: OPTICAL IMAGING MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 46 NORTH AMERICA: MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 47 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 48 NORTH AMERICA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 49 NORTH AMERICA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 50 NORTH AMERICA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 51 NORTH AMERICA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.2.2 US
11.2.2.1 Presence of several large hospitals & health systems to increase number of imaging & diagnostic procedures in country
TABLE 52 US: MACROECONOMIC INDICATORS
TABLE 53 US: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 54 US: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 55 US: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 56 US: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 57 US: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 58 US: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Availability of research funding to drive growth
TABLE 59 CANADA: MACROECONOMIC INDICATORS
TABLE 60 CANADA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 61 CANADA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 62 CANADA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 63 CANADA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 64 CANADA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 65 CANADA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT
FIGURE 31 EUROPE: OPTICAL IMAGING MARKET SNAPSHOT
TABLE 66 EUROPE: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 67 EUROPE: MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 68 EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 69 EUROPE: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 70 EUROPE: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 71 EUROPE: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 72 EUROPE: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Robust healthcare spending to support market in Germany
TABLE 73 GERMANY: MACROECONOMIC INDICATORS
TABLE 74 GERMANY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 75 GERMANY: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 76 GERMANY: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 77 GERMANY: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 78 GERMANY: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 79 GERMANY: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Increasing healthcare expenditure and rising medical tourism in France to propel growth
TABLE 80 FRANCE: MACROECONOMIC INDICATORS
TABLE 81 FRANCE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 82 FRANCE: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 83 FRANCE: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 84 FRANCE: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 85 FRANCE: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 86 FRANCE: IMAGING MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.4 UK
11.3.4.1 Growing adoption of optical imaging techniques and in vivo research applications to drive growth
TABLE 87 UK: MACROECONOMIC INDICATORS
TABLE 88 UK: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 89 UK: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 90 UK: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 91 UK: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 92 UK: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 93 UK: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Presence of major pharmaceutical & research institutes to drive market
TABLE 94 ITALY: MACROECONOMIC INDICATORS
TABLE 95 ITALY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 96 ITALY: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 97 ITALY: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 98 ITALY: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 99 ITALY: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 100 ITALY: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Increasing development in biomedical sciences to drive growth
TABLE 101 SPAIN: MACROECONOMIC INDICATORS
TABLE 102 SPAIN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 103 SPAIN: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 104 SPAIN: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 105 SPAIN: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 106 SPAIN: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 107 SPAIN: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 108 SHARE OF GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE) IN ROE COUNTRIES
TABLE 109 REST OF EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 110 REST OF EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 111 REST OF EUROPE: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 112 REST OF EUROPE: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 113 REST OF EUROPE: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 114 REST OF EUROPE: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 32 ASIA PACIFIC: OPTICAL IMAGING MARKET SNAPSHOT
TABLE 115 ASIA PACIFIC: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 116 ASIA PACIFIC: MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 117 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 118 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 119 ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 120 ASIA PACIFIC: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 121 ASIA PACIFIC: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Established pharmaceutical & biotechnology research base to propel market
TABLE 122 JAPAN: MACROECONOMIC INDICATORS
TABLE 123 JAPAN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 124 JAPAN: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 125 JAPAN: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 126 JAPAN: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 127 JAPAN: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 128 JAPAN: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.3 CHINA
11.4.3.1 Presence of large population base and favorable initiatives undertaken by authorities to aid growth
TABLE 129 CHINA: MACROECONOMIC INDICATORS
TABLE 130 CHINA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 131 CHINA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 132 CHINA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 133 CHINA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 134 CHINA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 135 CHINA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.4 INDIA
11.4.4.1 Rising adoption of advanced diagnostic imaging technologies by healthcare providers to boost market
TABLE 136 INDIA: MACROECONOMIC INDICATORS
TABLE 137 INDIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 138 INDIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 139 INDIA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 140 INDIA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 141 INDIA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 142 INDIA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.5 AUSTRALIA
11.4.5.1 Growing awareness of healthcare services and rising healthcare expenditure to support market
TABLE 143 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 144 AUSTRALIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 145 AUSTRALIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 146 AUSTRALIA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 147 AUSTRALIA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 148 AUSTRALIA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 149 AUSTRALIA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.6 SOUTH KOREA
11.4.6.1 Growing expenditure on improved healthcare services and rising geriatric population to propel growth
TABLE 150 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 151 SOUTH KOREA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 152 SOUTH KOREA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 153 SOUTH KOREA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 154 SOUTH KOREA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 155 SOUTH KOREA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 156 SOUTH KOREA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 157 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 158 REST OF ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 159 REST OF ASIA PACIFIC: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 160 REST OF ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 161 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 162 REST OF ASIA PACIFIC: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 163 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 164 LATIN AMERICA: MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 165 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 166 LATIN AMERICA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 167 LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 168 LATIN AMERICA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 169 LATIN AMERICA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 Improved GDP expenditure on healthcare
TABLE 170 BRAZIL: MACROECONOMIC INDICATORS
TABLE 171 BRAZIL: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 172 BRAZIL: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 173 BRAZIL: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 174 BRAZIL: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 175 BRAZIL: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 176 BRAZIL: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
TABLE 177 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 178 REST OF LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 179 REST OF LATIN AMERICA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 180 REST OF LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 181 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 182 REST OF LATIN AMERICA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 183 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 185 MIDDLE EAST & AFRICA: MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 186 MIDDLE EAST & AFRICA: MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
TABLE 187 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 188 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020-2027 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 183)
12.1 INTRODUCTION
FIGURE 33 KEY MARKET DEVELOPMENTS (JANUARY 2020 TO JANUARY 2023)
12.2 REVENUE SHARE ANALYSIS
FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET
12.3 MARKET SHARE ANALYSIS
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GLOBAL MARKET, 2021
12.4 COMPANY EVALUATION QUADRANT
12.4.1 STARS
12.4.2 EMERGING LEADERS
12.4.3 PERVASIVE PLAYERS
12.4.4 PARTICIPANTS
FIGURE 36 GLOBAL MARKET: GLOBAL COMPANY EVALUATION QUADRANT
12.5 START-UP/SME EVALUATION QUADRANT
12.5.1 PROGRESSIVE COMPANIES
12.5.2 STARTING BLOCKS
12.5.3 RESPONSIVE COMPANIES
12.5.4 DYNAMIC COMPANIES
FIGURE 37 GLOBAL MARKET: GLOBAL START-UP/SME MATRIX
12.6 COMPETITIVE BENCHMARKING
12.6.1 COMPANY FOOTPRINT FOR KEY PLAYERS
12.6.2 PRODUCT FOOTPRINT
12.6.3 TECHNIQUE FOOTPRINT
12.6.4 THERAPEUTIC AREA FOOTPRINT
12.6.5 REGIONAL FOOTPRINT
12.7 GEOGRAPHIC FOOTPRINT OF KEY PLAYERS
FIGURE 38 GEOGRAPHIC REVENUE MIX: KEY PLAYERS
12.8 COMPETITIVE SITUATION AND TRENDS
12.8.1 PRODUCT LAUNCHES & APPROVALS
TABLE 189 GLOBAL MARKET: PRODUCT LAUNCHES (JANUARY 2019 TO JANUARY 2023)
12.8.2 DEALS
TABLE 190 GLOBAL MARKET: DEALS(JANUARY 2019 TO JANUARY 2023)
12.8.3 OTHER DEVELOPMENTS
TABLE 191 GLOBAL MARKET: OTHER DEVELOPMENTS (JANUARY 2019 TO JANUARY 2023)
13 COMPANY PROFILES (Page No. - 200)
13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 CARL ZEISS MEDITEC AG
TABLE 192 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW
FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021)
13.1.2 TOPCON CORPORATION
TABLE 193 TOPCON CORPORATION: BUSINESS OVERVIEW
FIGURE 40 TOPCON CORPORATION: COMPANY SNAPSHOT (2021)
13.1.3 CANON INC.
TABLE 194 CANON INC.: BUSINESS OVERVIEW
FIGURE 41 CANON INC.: COMPANY SNAPSHOT (2021)
13.1.4 ABBOTT LABORATORIES INC.
TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 42 ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT (2021)
13.1.5 KONINKLIJKE PHILIPS N.V.
TABLE 196 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
13.1.6 PERKINELMER, INC.
TABLE 197 PERKINELMER, INC.: BUSINESS OVERVIEW
FIGURE 44 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
13.1.7 LEICA MICROSYSTEMS (DANAHER CORPORATION)
TABLE 198 LEICA MICROSYSTEMS (DANAHER CORPORATION): BUSINESS OVERVIEW
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
13.1.8 AGFA-GEVAERT N.V.
TABLE 199 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW
FIGURE 46 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2021)
13.1.9 HAMAMATSU PHOTONICS K.K.
TABLE 200 HAMAMATSU PHOTONICS K.K.: BUSINESS OVERVIEW
FIGURE 47 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2021)
13.2 OTHER PLAYERS
13.2.1 HEIDELBERG ENGINEERING, INC.
TABLE 201 HEIDELBERG ENGINEERING, INC.: BUSINESS OVERVIEW
13.2.2 HEADWALL PHOTONICS, INC.
TABLE 202 HEADWALL PHOTONICS, INC.: BUSINESS OVERVIEW
13.2.3 VISIONIX (FORMERLY LUNEAU TECHNOLOGY USA & OPTOVUE INC.)
TABLE 203 VISIONIX: BUSINESS OVERVIEW
13.2.4 OPTICAL IMAGING LTD.
TABLE 204 OPTICAL IMAGING LTD.: BUSINESS OVERVIEW
13.2.5 OPTOS
TABLE 205 OPTOS: BUSINESS OVERVIEW
13.2.6 WASATCH PHOTONICS
TABLE 206 WASATCH PHOTONICS: BUSINESS OVERVIEW
13.2.7 ARCSCAN INC.
TABLE 207 ARCSCAN INC.: BUSINESS OVERVIEW
13.2.8 DERMALUMICS
TABLE 208 DERMALUMICS: BUSINESS OVERVIEW
13.2.9 CYLITE PTY LTD.
TABLE 209 CYLITE PTY LTD.: BUSINESS OVERVIEW
13.2.10 MOPTIM
TABLE 210 MOPTIM: BUSINESS OVERVIEW
13.2.11 MICHELSON DIAGNOSTICS LTD.
TABLE 211 MICHELSON DIAGNOSTICS LTD.: BUSINESS OVERVIEW
13.2.12 THORLABS
TABLE 212 THORLABS: BUSINESS OVERVIEW
13.2.13 ITHERAMEDICAL
TABLE 213 ITHERAMEDICAL: BUSINESS OVERVIEW
13.2.14 KIBERO
TABLE 214 KIBERO: BUSINESS OVERVIEW
13.2.15 SENO MEDICAL
TABLE 215 SENO MEDICAL: BUSINESS OVERVIEW
13.2.16 ASPECTUS IMAGING
TABLE 216 ASPECTUS IMAGING: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 249)
14.1 INSIGHTS FROM INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 CUSTOMIZATION OPTIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
